Ann: NYR-BI03 Phase Ia Clinical Trial Update - Correction, page-45

  1. 1,232 Posts.
    lightbulb Created with Sketch. 157
    Full patent application has been submitted back in August. Common Zecs you do get how applications work. It’s who submits first and name a drug in the same drug class that has applied for a patent application. There is no other drug that is in this drug class for these structures. But good post. CEO stated patent approval expected to be cleared October this year but we don’t need it as a first to a submission has already been made. The patent is a formality non event



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
23.5¢
Change
0.000(0.00%)
Mkt cap ! $49.56M
Open High Low Value Volume
23.5¢ 24.0¢ 23.5¢ $91.85K 388.8K

Buyers (Bids)

No. Vol. Price($)
4 33986 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 28647 1
View Market Depth
Last trade - 14.03pm 26/06/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.